Compounding—Important Regulatory and Legislative Developments That Will Affect Your Practice

Monday, October 20, 2014, 8:00 am - 9:30 am
Austin Convention Center
Location: 17AB, Level 4
Continuing Education Credits: 1.5 (0.15 Contact Hours)
ACPE #: 207-000-14-223-L03-P and ACPE #: 207-000-14-223-L03-T

Vital information for all compounders! The implementation of DQSA is underway, bringing significant changes in compounding that will affect your business. This session will give insight on FDA's implementation of the new outsourcing facility category as well as further guidance regarding traditional compounding. Additionally, the program will feature up to the minute information on what you need to know to prepare for USP's recently proposed chapter on handling of hazardous drugs. This General Chapter <800> may well require new investment in equipment, and negative pressure rooms for all providers of BHRT, among other things.

Pharmacist and Technician Learning Objectives:

  1. Summarize developments in the implementation of Drug Quality and Safety Act (DQSA)

  2. Discuss FDA's actions on the newly created outsourcing facility classification.

  3. Explain the provisions in USP General Chapter <800> and its implications for community practice compounders.

Speaker: TBD

Activity Type: Application-based
Audience: Pharmacists and Pharmacy Technicians